Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

Oct 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Category growth driven by COVID-19 concerns and local inflation

Cough, cold and allergy (hay fever) remedies will benefit from the increased health concerns during COVID-19 in 2020, as these products are aimed at some of the key symptoms of COVID-19. Like analgesics, this category is expected to show quite strong growth in the first quarter of 2020, with significant gains across all subcategories.

Theraflu almost synonymous with flu medication as Fervex and Coldrex lose favour

The Theraflu brand is indisputably the leader of cough, cold and allergy (hay fever) remedies. Introduced to the category relatively recently, Theraflu has led the category since 2017, and is expected to increase its value share once more in 2020.

Local manufacturers struggle in the face of competition from global players

In general, local manufacturers are not very successful in this category. Domestic manufacturers tend to struggle against significant competition from global players who have developed a very good reputation as effective products in tackling diseases.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Uzbekistan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Uzbekistan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan?
What are the major brands in Uzbekistan?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Category growth driven by COVID-19 concerns and local inflation

Theraflu almost synonymous with flu medication as Fervex and Coldrex lose favour

Local manufacturers struggle in the face of competition from global players

RECOVERY AND OPPORTUNITIES

Demand for convenient combination products continues to grow as new innovative and effective products enter the mix

Category set to grow in forecast period with room for expansion as paediatric cough, cold and allergy remedies is set to grow

Global companies will remain major players despite government efforts to boost local manufacturers

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Category growth driven by COVID-19 concerns and local inflation

Theraflu almost synonymous with flu medication as Fervex and Coldrex lose favour

Local manufacturers struggle in the face of competition from global players

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Uzbekistan - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Category growth driven by COVID-19 concerns and local inflation

Theraflu almost synonymous with flu medication as Fervex and Coldrex lose favour

Local manufacturers struggle in the face of competition from global players

RECOVERY AND OPPORTUNITIES

Demand for convenient combination products continues to grow as new innovative and effective products enter the mix

Category set to grow in forecast period with room for expansion as paediatric cough, cold and allergy remedies is set to grow

Global companies will remain major players despite government efforts to boost local manufacturers

CATEGORY DATA

Consumer Health in Uzbekistan - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports